e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?
Amornpun Wongkarnjana, Christopher J. Ryerson
Source:
Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020
Journal Issue:
June
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Amornpun Wongkarnjana, Christopher J. Ryerson. Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?. Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
The new challenge of CTD-ILD: from basic science to clinical setting
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Interstitial lung disease in systemic sclerosis: where do we stand?
Source: Eur Respir Rev 2015; 24: 411-419
Year: 2015
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Cystic interstitial lung disease - a rare disease?
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015
From life threatening to chronic connective tissue disease-associated interstitial lung disease: all you need to know
Source: Virtual Congress 2020 – From life threatening to chronic connective tissue disease-associated interstitial lung disease (CTD-ILD): all you need to know
Year: 2020
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Year: 2019
Interstitial lung disease: ?course report
Source: Breathe, 16 (3) 200075; 10.1183/20734735.0075-2020
Year: 2020
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?
Source: Eur Respir J, 53 (2) 1800994; 10.1183/13993003.00994-2018
Year: 2019
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?
Source: Eur Respir J, 53 (2) 1801939; 10.1183/13993003.01939-2018
Year: 2019
Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011
What’s new in interstitial lung diseases in children?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021
Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
Source: Eur Respir J, 56 (6) 2003967; 10.1183/13993003.03967-2020
Year: 2020
Genetics of fibrosing lung diseases
Source: Eur Respir J 2005; 25: 915-927
Year: 2005
Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept